Miconazole 7
NDC Package 61269-736-07

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Miconazole 7 is a . Marketed by H2-pharma, Llc, this product is identified by NDC 61269-736 and is authorized under FDA application ANDA073507.

Identification & Billing

NDC Package Code
61269-736-07
Package Description
7 SUPPOSITORY in 1 BOX
Product Code
61269-736
11-Digit Billing Format
61269073607
Billing Unit
EA - Billing unit of "each" is used when the product is dispensed in discreet units.
Units Per Package
7 EA

Clinical Specifications

Proprietary Name
Miconazole 7
Dosage Form
-

Regulatory & Marketing

Labeler Name
H2-pharma, Llc
FDA Application #
ANDA073507
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
05-24-2021
End Marketing Date
07-31-2025
Listing Expiration
07-31-2025
Exclude Flag
D
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 61269-736-07 identifies a specific commercial package of 7 suppository in 1 box of Miconazole 7, labeled by H2-pharma, Llc. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by H2-pharma, Llc on May 24, 2021. The current certification is valid through July 31, 2025.

How is this H2-pharma, Llc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 61269073607. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 7 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
61269-736-07
11-Digit CMS (5-4-2)
61269-0736-07

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.